MANH vs TECH · P/E 57, rev $1.04B vs P/E 65, rev $1.22B
Manhattan Associates Inc (MANH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Manhattan Associates Inc (MANH) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MANH revenue for 2024-12-31 was $1.04B. Net income was $218.4M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. MANH currently screens at market cap $12.14B and trailing P/E 57.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MANH currently screens at market cap $12.14B and trailing P/E 57.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MANH and TECH stock pages for the full models.
Not investment advice.